{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":24,"next":"https://hottub.news/v1/items?before=1794321509.9474790&entity=Q204711","sponsored":0,"items":[{"id":"n_slgsxgbjfizidemacw2q","seq":10939281,"kind":"article","title":"AZN : FDA Okays IMFINZI Combination Regimen For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer","url":"https://www.finanzen.ch/nachrichten/aktien/azn-fda-okays-imfinzi-combination-regimen-for-cisplatin-ineligible-muscle-invasive-bladder-cancer-1036763892","published":"2026-11-14T02:23:00Z","seen":"2026-11-14T02:23:00Z","lang":"en","country":"CH","source":{"id":"finanzen.ch","name":"finanzen.ch","domain":"finanzen.ch"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q19904005","name":"durvalumab","type":"other"},{"id":"Q412415","name":"cisplatin","type":"other"},{"id":"Q53620955","name":"Muscle-invasive bladder cancer","type":"other"}],"story":"st_quq3xk4j2o5k3r5ifd2a","category":"health","category_p":0.37,"sentiment":"neutral","tone":-0.18,"political":0.33},{"id":"n_33cylopgnw5ayni4tytq","seq":10929623,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained","url":"https://www.kmbc.com/article/fdas-warning-glp-1s-blindness/74426101","published":"2026-11-14T01:20:00Z","seen":"2026-11-14T01:20:00Z","lang":"en","country":"US","source":{"id":"kmbc.com","name":"kmbc.com","domain":"kmbc.com","outlet":{"wikidata":"Q6657537","name":"KMBC-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.83,"sentiment":"negative","tone":-0.78,"political":0.17},{"id":"n_vfsbtc373ssos53awekq","seq":10476322,"kind":"article","title":"FDA's new warning about GLP-1s and blindness explained – PolitiFact","url":"https://politifact.com/article/2026/nov/12/fda-glp1-warning-blindness-vision-loss-naion","published":"2026-11-12T21:30:00Z","seen":"2026-11-12T22:36:24Z","lang":"en","country":"US","source":{"id":"politifact.com","name":"politifact.com","domain":"politifact.com","outlet":{"wikidata":"Q3394318","name":"PolitiFact","type":"website","country":"US","designations":["fact-checking organisation","organization","website"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q3394318","name":"PolitiFact","type":"org"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.69,"sentiment":"negative","tone":-0.76,"political":0.49},{"id":"n_jxr7pd7vyk2llxnmeafq","seq":10391504,"kind":"article","title":"Novo, Lilly drugs to carry new FDA eye risk warning","url":"http://www.nashvilleherald.com/news/279424298/novo-lilly-drugs-to-carry-new-fda-eye-risk-warning","published":"2026-11-12T18:13:47Z","seen":"2026-11-12T18:13:47Z","lang":"en","source":{"id":"nashvilleherald.com","name":"nashvilleherald.com","domain":"nashvilleherald.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q818846","name":"Novo","type":"org"},{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_yzzhtm47hwdneiowi5aa","category":"health","category_p":0.72,"sentiment":"neutral","tone":-0.22,"political":0.1},{"id":"n_hdderc4sb6skbnjlg6wq","seq":10352625,"kind":"article","title":"First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer","url":"http://www.sydneysun.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer","published":"2026-11-12T16:15:00Z","seen":"2026-11-12T16:33:50Z","lang":"en","source":{"id":"sydneysun.com","name":"sydneysun.com","domain":"sydneysun.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_rczcaihv4rz3rdqhax6q","category":"health","category_p":0.7,"sentiment":"positive","tone":0.03,"political":0.07},{"id":"n_pvmfwxn3zu5rjxmykora","seq":10316352,"kind":"article","title":"FDA orders eye risk warnings for Ozempic, Zepbound","url":"http://www.bignewsnetwork.com/news/279424298/fda-orders-eye-risk-warnings-for-ozempic-zepbound","published":"2026-11-12T14:15:00Z","seen":"2026-11-12T14:56:40Z","lang":"en","country":"AE","source":{"id":"bignewsnetwork.com","name":"bignewsnetwork.com","domain":"bignewsnetwork.com","outlet":{"wikidata":"Q65068562","name":"Big News Network","type":"magazine","country":"AE","designations":["news magazine"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_ip5lwh6i62lc5aqavsnq","category":"health","category_p":0.61,"sentiment":"neutral","tone":-0.28,"political":0.08},{"id":"n_235jhznmms7qvnpqfmfa","seq":10291724,"kind":"article","title":"Предупреждение за риск за зрението от GLP-1 изиска FDA","title_en":"Warning about vision risk from GLP-1 issued by FDA","url":"https://www.puls.bg/aktsenti-c-16/preduprezhdenie-za-risk-za-zrenieto-ot-glp-1-iziska-fda-n-59227","summary":"Независимо от ползите на GLP-1 за лечение на диабет и отслабване те не са безусловно безопасни и следва да се обръща внимание на продупрежденията","published":"2026-11-12T13:52:40Z","seen":"2026-11-12T13:52:40Z","lang":"bg","country":"BG","source":{"id":"kite-puls-bg-f1e4b3","name":"puls.bg","domain":"puls.bg"},"via":"kite-puls-bg-f1e4b3","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.puls.bg/cache/9/c/b/9/d/9cb9d48657f199f2ef132ec3691c0b0bd1a1b9fa.jpeg","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.71,"sentiment":"negative","tone":-0.61,"political":0.24},{"id":"n_nuulqvqmmb7wkirs4v4q","seq":10211003,"kind":"article","title":"تسبب العمى.. إدارة الغذاء والدواء الأمريكية تحذر من حقن التخسيس","title_en":"Blindness caused.. US FDA warns against weight loss injections","url":"https://www.elbalad.news/7177596","summary":"تخضع حقن التخسيس وإنقاص الوزن الشائعة، بما في ذلك أوزمبيك وويجوفي ومونجارو، لتدقيق جديد بشأن سلامتها بعد أن أشارت إدارة الغذاء والدواء الأمريكية إلى خطر محتمل للإصابة بحالة نادرة في العين قد تُسبب فقد صدى البلد : المصدر تسبب العمى.. إدارة الغذاء والدواء الأمريكية تحذر من حقن التخسيس","published":"2026-11-12T09:30:00Z","seen":"2026-11-12T09:32:05Z","lang":"ar","country":"EG","source":{"id":"kite-elbalad-news-c10dcc","name":"elbalad.news","domain":"elbalad.news","outlet":{"wikidata":"Q63121712","name":"Sada El Balad","type":"website","country":"EG","designations":["website"]}},"via":"kite-elbalad-news-c10dcc","topics":["middle-east"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://media.elbalad.news/2026/11/large/594677143268202611120842524252.jpg","story":"st_au4oi7gtsvqfkhjdevoq","category":"health","category_p":0.91,"sentiment":"negative","tone":-0.87,"political":0.22},{"id":"n_fpcfzg5bzhduchzbyaua","seq":9994786,"kind":"article","title":"《TAIPEI TIMES》 GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns","title_en":"FDA warns that GLP-1 weight-loss drugs can cause blindness in rare cases.","url":"https://news.ltn.com.tw/news/focus/breakingnews/5637650","summary":"By Jonathan Chin / Staff writer, with CNA Taiwan is weighing its first-ever compensation claim ov...…","published":"2026-11-11T19:00:00Z","seen":"2026-11-11T19:38:59Z","lang":"zh","country":"TW","source":{"id":"kite-news-ltn-com-tw-3ff025","name":"news.ltn.com.tw","domain":"news.ltn.com.tw"},"via":"kite-news-ltn-com-tw-3ff025","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.69,"sentiment":"negative","tone":-0.67,"political":0.2},{"id":"n_mnizrscdsbudc67hmjqa","seq":9948849,"kind":"article","title":"GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns","url":"https://www.taipeitimes.com/News/front/archives/2026/11/12/2003867590","published":"2026-11-11T17:00:00Z","seen":"2026-11-11T17:25:18Z","lang":"en","country":"TW","source":{"id":"taipeitimes.com","name":"taipeitimes.com","domain":"taipeitimes.com","outlet":{"wikidata":"Q714427","name":"Taipei Times","type":"newspaper","country":"TW","designations":["newspaper","online newspaper","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health","politics"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.83,"sentiment":"negative","tone":-0.71,"political":0.07},{"id":"n_v77l3jsbq6ma2xwr2ixa","seq":9888579,"kind":"article","title":"FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic","url":"https://www.thehindubusinessline.com/news/fda-flags-rare-vision-loss-risk-with-glp-1-drugs-doctors-say-patients-need-not-panic/article71690072.ece","summary":"Indian endocrinologists, however, say the risk appears small and patients should not panic, while stressing on eye examinations if symptoms develop","published":"2026-11-11T14:13:27Z","seen":"2026-11-11T14:38:58Z","lang":"en","country":"IN","source":{"id":"kite-thehindubusinessline-com-b0e07f","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindubusinessline-com-b0e07f","topics":["news"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://bl-i.thgim.com/public/incoming/gkt5r0/article71690231.ece/alternates/LANDSCAPE_1200/IMG_iStock-2238129175_2_1_7KFR1MO5.jpg","mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.88,"sentiment":"negative","tone":-0.42,"political":0.07},{"id":"n_gbklbngay47woqt5z7yq","seq":9842295,"kind":"article","title":"FDA cảnh báo nguy cơ mất thị lực từ thuốc giảm cân","title_en":"FDA warns of risk of vision loss from weight loss drugs","url":"https://kenh14.vn/fda-canh-bao-nguy-co-mat-thi-luc-tu-thuoc-giam-can-215261111172706507.chn","summary":"Mỹ yêu cầu bổ sung cảnh báo cho nhóm thuốc GLP-1, gồm Ozempic và Wegovy, về nguy cơ mắc một bệnh hiếm gặp có thể gây mất thị lực vĩnh viễn.","published":"2026-11-11T12:24:01Z","seen":"2026-11-11T12:24:01Z","lang":"vi","country":"VN","source":{"id":"kite-kenh14-vn-c7321a","name":"kenh14.vn","domain":"kenh14.vn","outlet":{"wikidata":"Q18459294","name":"Kênh 14","type":"website","country":"VN","designations":["website"]}},"via":"kite-kenh14-vn-c7321a","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_au4oi7gtsvqfkhjdevoq","category":"health","category_p":0.81,"sentiment":"negative","tone":-0.85,"political":0.05},{"id":"n_mvn2ztchv7lelsa55w6q","seq":9842670,"kind":"article","title":"FDA requires safety label changes for GLP-1s over risk for eye condition","url":"https://www.kxan.com/news/fda-requires-safety-label-changes-for-glp-1s-over-risk-for-eye-condition","summary":"NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.","published":"2026-11-11T12:20:24Z","seen":"2026-11-11T12:25:30Z","lang":"en","country":"US","source":{"id":"kite-kxan-com-6bd633","name":"kxan.com","domain":"kxan.com","outlet":{"wikidata":"Q6341047","name":"KXAN-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-kxan-com-6bd633","topics":["austin-tx","national news","news","top stories"],"authors":["Zach Kaplan"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q5572286","name":"glucagon-like peptide-1 agonist","type":"other"}],"image":"https://www.kxan.com/wp-content/uploads/sites/40/2026/11/GettyImages-2279484867_693208-e1783009938301_65d91c.jpg?w=900","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.56,"sentiment":"negative","tone":-0.49,"political":0.13},{"id":"n_xh7ar2tz6bomspzwymfa","seq":9740679,"kind":"article","title":"FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning","url":"https://www.thehindubusinessline.com/latest-news/fda-flags-possible-risk-of-rare-eye-condition-with-glp-1-drugs-orders-new-safety-warning/article71688508.ece","published":"2026-11-11T06:24:00Z","seen":"2026-11-11T06:43:08Z","lang":"en","country":"IN","source":{"id":"thehindubusinessline.com","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.62,"sentiment":"negative","tone":-0.74,"political":0.12},{"id":"n_hrpn74hrrgzp3d7wugwq","seq":9684172,"kind":"article","title":"FDA authorizes emergency screwworm treatment as Arizona sees cases","url":"https://www.kold.com/2026/11/10/fda-authorizes-emergency-screwworm-treatment-arizona-sees-cases","published":"2026-11-11T02:08:00Z","seen":"2026-11-11T02:08:00Z","lang":"en","country":"US","source":{"id":"kold.com","name":"kold.com","domain":"kold.com","outlet":{"wikidata":"Q3191458","name":"KMSB","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q816","name":"Arizona","type":"place"}],"story":"st_vydm5ikd3qljwkgxi3bq","category":"health","category_p":0.69,"sentiment":"neutral","tone":-0.32,"political":0.18},{"id":"n_crarqscwsr6gna36mcia","seq":9664850,"kind":"article","title":"“시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포","title_en":"Food and Drug Administration distributes letter on safety of GLP-1 obesity treatment","url":"https://kormedi.com/2902989","summary":"비만치료에 사용되는 글루카곤유사펩타이드-1(GLP-1) 계열 의약품의 시력 저하 부작용이 꾸준히 지적되면서, 국내 식품의약품안전처도 안전조치를 추진하기로 결정했다. 식약처는 의약 전문가와… The post “시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포 appeared first on 코메디닷컴 .","published":"2026-11-11T00:51:08Z","seen":"2026-11-11T00:54:02Z","lang":"ko","country":"KR","source":{"id":"kite-kormedi-com-1cc5b2","name":"kormedi.com","domain":"kormedi.com","outlet":{"wikidata":"Q24858392","name":"Kormedi.com","type":"newspaper","country":"KR","designations":["online newspaper"]}},"via":"kite-kormedi-com-1cc5b2","topics":["medicine","바이오·제약","의료","glp-1","마운자로","비만약","비만치료제","에페"],"authors":["장자원 기자"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://kormedi.com/wp-content/uploads/2026/11/2026-11-11-93752-edited.png","story":"st_s7hy467hhfdgv77aaklq","category":"health","category_p":0.89,"sentiment":"negative","tone":-0.56,"political":0.2},{"id":"n_ozvtiegpm2y6pbj3zliq","seq":9653451,"kind":"article","title":"비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부","title_en":"What to do if you experience vision problems after taking obesity medication?... FDA issues warning","url":"https://www.segye.com/newsView/20261111503314","summary":"식품의약품안전처는 글루카곤 유사 펩타이드-1(GLP-1) 계열 의약품 사용시 비동맥 전방 허혈성 시신경병증(NAION)이 의심되면 투약을 중단하도록 하는 내용의 '의약품 안전성 서한'을 배포했다고 11일 밝혔다. 이는 비만 치료 등에 사용하는 GLP-1 계열 의약품이 NAION 위험을 증가시킬 수 있다는 해외 안전성 정보에 따른 조처다. 앞서 미","published":"2026-11-10T23:40:13Z","seen":"2026-11-10T23:56:01Z","lang":"ko","country":"KR","source":{"id":"kite-segye-com-7df8f9","name":"segye.com","domain":"segye.com","outlet":{"wikidata":"Q624291","name":"Segye Ilbo","type":"newspaper","country":"KR","designations":["daily newspaper"]}},"via":"kite-segye-com-7df8f9","entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_ozvtiegpm2y6pbj3zliq","category":"health","category_p":0.91,"sentiment":"neutral","tone":-0.42,"political":0.04},{"id":"n_3qnn2cfwukfxhpmdrn7a","seq":9611295,"kind":"article","title":"FDA, GLP1 kilo verme ilaçları için körlük riski uyarısında bulundu","title_en":"FDA warns of blindness risk for GLP1 weight loss drugs","url":"https://www.trthaber.com/haber/dunya/fda-glp-1-kilo-verme-ilaclari-icin-korluk-riski-uyarisinda-bulundu-962864.html","summary":"Amerikan Gıda ve İlaç Dairesi FDA, Ozempic, Wegovy ve Mounjaro gibi popüler GLP1 sınıfı kilo verme ve diyabet ilaçlarının uyarı etiketlerine nadir görülen ve kalıcı körlüğe yol açabilen bir göz rahatsızlığı riskinin eklenmesini zorunlu kıldı.","published":"2026-11-10T21:23:00Z","seen":"2026-11-10T21:40:51Z","lang":"tr","country":"TR","source":{"id":"kite-trthaber-com-699107","name":"trthaber.com","domain":"trthaber.com","outlet":{"wikidata":"Q535725","name":"TRT Haber","type":"broadcaster","country":"TR","designations":["specialty channel","television station"]}},"via":"kite-trthaber-com-699107","topics":["dünya"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.81,"sentiment":"negative","tone":-0.71,"political":0.08},{"id":"n_smclfzhf6agnxx7bhztq","seq":9558166,"kind":"article","title":"FDA approves Sunharbo, factor XIa inhibitor for reducing stroke","url":"https://www.healio.com/news/neurology/20261110/fda-approves-sunharbo-first-factor-xia-inhibitor-for-reducing-risk-for-secondary-stroke","summary":"The FDA has approved Sunharbo, the only approved factor XIa inhibitor intended to reduce the risk for stroke in adults who recently experienced a non-cardioembolic ischemic stroke or high-risk transient ischemic attack. With the approval, physicians now have a treatment option that can lower patient risk for secondary stroke, which can come with more severe outcomes than incident strokes, said Ashkan Shoamanesh, MD, senior scientist with the Population Health Research…","published":"2026-11-10T18:31:57Z","seen":"2026-11-10T18:52:50Z","lang":"en","source":{"id":"kite-healio-com-23151b","name":"healio.com","domain":"healio.com"},"via":"kite-healio-com-23151b","topics":["medicine"],"authors":["Shawn Arrajj"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.46,"category2":"science-technology","sentiment":"positive","tone":0.36,"political":0.13},{"id":"n_3d36kpn55f7vnlsjakoa","seq":9558454,"kind":"article","title":"FDA orders new warning on GLP-1 drugs over potential risk of blindness","url":"https://www.thenationalnews.com/future/science/2026/11/10/do-glps1s-cause-blindness","published":"2026-11-10T18:15:00Z","seen":"2026-11-10T18:50:54Z","lang":"en","country":"AE","source":{"id":"thenationalnews.com","name":"thenationalnews.com","domain":"thenationalnews.com","outlet":{"wikidata":"Q2544289","name":"The National","type":"newspaper","country":"AE","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Cody Combs"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.68,"sentiment":"negative","tone":-0.74,"political":0.2},{"id":"n_epxedqmney23apwbjc7a","seq":9531826,"kind":"article","title":"FDA adds rare vision-loss warning to popular GLP-1 drugs","url":"https://www.ksla.com/2026/11/09/fda-adds-rare-vision-loss-warning-popular-glp-1-drugs","published":"2026-11-10T17:30:00Z","seen":"2026-11-10T17:33:26Z","lang":"en","country":"US","source":{"id":"ksla.com","name":"ksla.com","domain":"ksla.com","outlet":{"wikidata":"Q6337868","name":"KSLA","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.79,"sentiment":"negative","tone":-0.65,"political":0.07},{"id":"n_fhwacpeygtn7keusmzoa","seq":9531677,"kind":"article","title":"FDA WARNING: Ozempic, Wegovy And Other GLP-1 Drugs To Carry Warning About Rare Vision-Loss Risk","url":"https://www.theyeshivaworld.com/news/general/2621322/fda-warning-ozempic-wegovy-and-other-glp-1-drugs-to-carry-warning-about-rare-vision-loss-risk.html","published":"2026-11-10T17:30:00Z","seen":"2026-11-10T17:33:26Z","lang":"en","source":{"id":"theyeshivaworld.com","name":"theyeshivaworld.com","domain":"theyeshivaworld.com","outlet":{"wikidata":"Q8052863","name":"Yeshiva World News","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_ip5lwh6i62lc5aqavsnq","category":"health","category_p":0.69,"sentiment":"negative","tone":-0.74,"political":0.1},{"id":"n_obwaxuyygw5l2ha643fa","seq":9491113,"kind":"article","title":"FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss","url":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","summary":"The risk appears small and data is mixed, but FDA wants patients to be aware.","published":"2026-11-10T14:43:49Z","seen":"2026-11-10T15:39:44Z","lang":"en","source":{"id":"kite-arstechnica-com-2ec921","name":"arstechnica.com","domain":"arstechnica.com","outlet":{"wikidata":"Q584152","name":"Ars Technica","type":"website","designations":["news website"]}},"via":"kite-arstechnica-com-2ec921","topics":["smart-home","health","eye","fda","glp-1","naion","ophthalmology"],"authors":["Beth Mole"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://cdn.arstechnica.net/wp-content/uploads/2026/02/GettyImages-1716643505-500x500.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.79,"sentiment":"negative","tone":-0.71,"political":0.13},{"id":"n_kwzduzt5uphi6k4opl3q","seq":9474790,"kind":"article","title":"STAT+: GLP-1s are given an FDA warning for rare eye condition risk","url":"https://www.statnews.com/2026/11/10/biotech-news-glp-1-given-an-fda-warning-for-rare-eye-condition-risk","summary":"The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”","published":"2026-11-10T14:38:29Z","seen":"2026-11-10T14:46:56Z","lang":"en","country":"US","source":{"id":"kite-statnews-com-165bdc","name":"statnews.com","domain":"statnews.com","outlet":{"wikidata":"Q28452506","name":"Stat","type":"website","designations":["business","news website","website"]}},"via":"kite-statnews-com-165bdc","topics":["healthcare","usa","biotech","business","pharma","the readout","biotechnology","clinical trials"],"authors":["Elaine Chen"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://www.statnews.com/wp-content/uploads/2025/11/AdobeStock_1666420823-645x645.jpeg","mentions":3,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.68,"sentiment":"negative","tone":-0.49,"political":0.13}]}